vs

Side-by-side financial comparison of Inotiv, Inc. (NOTV) and SunOpta Inc. (STKL). Click either name above to swap in a different company.

SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $120.9M, roughly 1.7× Inotiv, Inc.). SunOpta Inc. runs the higher net margin — 0.4% vs -23.5%, a 23.9% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs 0.8%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $-10.6M). Over the past eight quarters, SunOpta Inc.'s revenue compounded faster (7.4% CAGR vs 0.8%).

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business u...

SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.

NOTV vs STKL — Head-to-Head

Bigger by revenue
STKL
STKL
1.7× larger
STKL
$205.4M
$120.9M
NOTV
Growing faster (revenue YoY)
STKL
STKL
+15.7% gap
STKL
16.6%
0.8%
NOTV
Higher net margin
STKL
STKL
23.9% more per $
STKL
0.4%
-23.5%
NOTV
More free cash flow
STKL
STKL
$22.7M more FCF
STKL
$12.1M
$-10.6M
NOTV
Faster 2-yr revenue CAGR
STKL
STKL
Annualised
STKL
7.4%
0.8%
NOTV

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
NOTV
NOTV
STKL
STKL
Revenue
$120.9M
$205.4M
Net Profit
$-28.4M
$816.0K
Gross Margin
12.4%
Operating Margin
-13.5%
3.3%
Net Margin
-23.5%
0.4%
Revenue YoY
0.8%
16.6%
Net Profit YoY
-2.7%
113.1%
EPS (diluted)
$-0.83
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NOTV
NOTV
STKL
STKL
Q4 25
$120.9M
Q3 25
$138.1M
$205.4M
Q2 25
$130.7M
$191.5M
Q1 25
$124.3M
$201.6M
Q4 24
$119.9M
$193.9M
Q3 24
$130.4M
$175.9M
Q2 24
$105.8M
$169.5M
Q1 24
$119.0M
$184.4M
Net Profit
NOTV
NOTV
STKL
STKL
Q4 25
$-28.4M
Q3 25
$-8.6M
$816.0K
Q2 25
$-17.6M
$4.4M
Q1 25
$-14.9M
$4.8M
Q4 24
$-27.6M
$-8.7M
Q3 24
$-18.9M
$-6.2M
Q2 24
$-26.1M
$-5.3M
Q1 24
$-48.1M
$2.9M
Gross Margin
NOTV
NOTV
STKL
STKL
Q4 25
Q3 25
12.4%
Q2 25
14.8%
Q1 25
15.0%
Q4 24
10.9%
Q3 24
13.0%
Q2 24
12.5%
Q1 24
16.8%
Operating Margin
NOTV
NOTV
STKL
STKL
Q4 25
-13.5%
Q3 25
-4.9%
3.3%
Q2 25
-4.3%
5.5%
Q1 25
-2.4%
5.2%
Q4 24
-12.9%
1.4%
Q3 24
-10.1%
0.5%
Q2 24
-19.6%
1.2%
Q1 24
-36.2%
5.5%
Net Margin
NOTV
NOTV
STKL
STKL
Q4 25
-23.5%
Q3 25
-6.2%
0.4%
Q2 25
-13.5%
2.3%
Q1 25
-12.0%
2.4%
Q4 24
-23.0%
-4.5%
Q3 24
-14.5%
-3.5%
Q2 24
-24.7%
-3.1%
Q1 24
-40.4%
1.6%
EPS (diluted)
NOTV
NOTV
STKL
STKL
Q4 25
$-0.83
Q3 25
$-0.14
$0.01
Q2 25
$-0.51
$0.03
Q1 25
$-0.44
$0.04
Q4 24
$-1.02
$-0.08
Q3 24
$-0.73
$-0.05
Q2 24
$-1.00
$-0.04
Q1 24
$-1.86
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NOTV
NOTV
STKL
STKL
Cash + ST InvestmentsLiquidity on hand
$12.7M
$2.2M
Total DebtLower is stronger
$405.8M
$250.8M
Stockholders' EquityBook value
$109.0M
$162.8M
Total Assets
$734.3M
$694.1M
Debt / EquityLower = less leverage
3.72×
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NOTV
NOTV
STKL
STKL
Q4 25
$12.7M
Q3 25
$21.7M
$2.2M
Q2 25
$6.2M
$2.2M
Q1 25
$19.3M
$2.3M
Q4 24
$38.0M
$1.6M
Q3 24
$21.4M
$2.9M
Q2 24
$14.4M
$3.2M
Q1 24
$32.7M
$1.5M
Total Debt
NOTV
NOTV
STKL
STKL
Q4 25
$405.8M
Q3 25
$402.1M
$250.8M
Q2 25
$396.5M
$263.3M
Q1 25
$399.5M
$260.6M
Q4 24
$396.0M
$265.2M
Q3 24
$393.3M
$289.9M
Q2 24
$382.4M
$303.1M
Q1 24
$380.6M
$258.8M
Stockholders' Equity
NOTV
NOTV
STKL
STKL
Q4 25
$109.0M
Q3 25
$136.0M
$162.8M
Q2 25
$143.8M
$159.8M
Q1 25
$157.7M
$154.8M
Q4 24
$169.8M
$148.6M
Q3 24
$170.5M
$155.0M
Q2 24
$182.1M
$158.8M
Q1 24
$207.2M
$163.6M
Total Assets
NOTV
NOTV
STKL
STKL
Q4 25
$734.3M
Q3 25
$771.1M
$694.1M
Q2 25
$759.7M
$704.9M
Q1 25
$766.0M
$690.7M
Q4 24
$772.9M
$668.5M
Q3 24
$781.4M
$699.3M
Q2 24
$774.6M
$704.7M
Q1 24
$815.4M
$671.8M
Debt / Equity
NOTV
NOTV
STKL
STKL
Q4 25
3.72×
Q3 25
2.96×
1.54×
Q2 25
2.76×
1.65×
Q1 25
2.53×
1.68×
Q4 24
2.33×
1.78×
Q3 24
2.31×
1.87×
Q2 24
2.10×
1.91×
Q1 24
1.84×
1.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NOTV
NOTV
STKL
STKL
Operating Cash FlowLast quarter
$-5.4M
$16.3M
Free Cash FlowOCF − Capex
$-10.6M
$12.1M
FCF MarginFCF / Revenue
-8.8%
5.9%
Capex IntensityCapex / Revenue
4.3%
2.1%
Cash ConversionOCF / Net Profit
20.03×
TTM Free Cash FlowTrailing 4 quarters
$-28.7M
$36.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NOTV
NOTV
STKL
STKL
Q4 25
$-5.4M
Q3 25
$14.3M
$16.3M
Q2 25
$-7.4M
$-4.5M
Q1 25
$-12.8M
$22.3M
Q4 24
$-4.5M
$33.1M
Q3 24
$-2.4M
$17.2M
Q2 24
$-14.8M
$-5.6M
Q1 24
$16.9M
$5.3M
Free Cash Flow
NOTV
NOTV
STKL
STKL
Q4 25
$-10.6M
Q3 25
$11.6M
$12.1M
Q2 25
$-11.5M
$-9.2M
Q1 25
$-18.3M
$9.5M
Q4 24
$-9.0M
$24.0M
Q3 24
$-7.7M
$11.7M
Q2 24
$-19.2M
$-15.3M
Q1 24
$9.9M
$-2.3M
FCF Margin
NOTV
NOTV
STKL
STKL
Q4 25
-8.8%
Q3 25
8.4%
5.9%
Q2 25
-8.8%
-4.8%
Q1 25
-14.7%
4.7%
Q4 24
-7.5%
12.4%
Q3 24
-5.9%
6.6%
Q2 24
-18.2%
-9.0%
Q1 24
8.3%
-1.2%
Capex Intensity
NOTV
NOTV
STKL
STKL
Q4 25
4.3%
Q3 25
1.9%
2.1%
Q2 25
3.1%
2.5%
Q1 25
4.4%
6.3%
Q4 24
3.7%
4.7%
Q3 24
4.1%
3.2%
Q2 24
4.2%
5.7%
Q1 24
5.9%
4.1%
Cash Conversion
NOTV
NOTV
STKL
STKL
Q4 25
Q3 25
20.03×
Q2 25
-1.03×
Q1 25
4.63×
Q4 24
Q3 24
Q2 24
Q1 24
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NOTV
NOTV

Research Models And Services Segment$72.9M60%
Discovery And Safety Assessment Segment$48.0M40%

STKL
STKL

Beverages And Broths$161.4M79%
Fruit Snacks$40.9M20%
Ingredients$3.1M2%

Related Comparisons